Barent DuBois

692 total citations
21 papers, 474 citations indexed

About

Barent DuBois is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Barent DuBois has authored 21 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Barent DuBois's work include Pharmacogenetics and Drug Metabolism (7 papers), Birth, Development, and Health (4 papers) and Pregnancy and preeclampsia studies (3 papers). Barent DuBois is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Birth, Development, and Health (4 papers) and Pregnancy and preeclampsia studies (3 papers). Barent DuBois collaborates with scholars based in United States, France and Denmark. Barent DuBois's co-authors include Yves Agid, Bernard Deweer, B. Pillon, Ganesh Cherala, Reza Mehvar, Frank Z. Stanczyk, B. Mazièré, H Cambon, J. Blin and Jean‐Claude Baron and has published in prestigious journals such as PLoS ONE, Diabetes and Journal of Medicinal Chemistry.

In The Last Decade

Barent DuBois

20 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barent DuBois United States 10 153 133 115 93 79 21 474
Monica Storti Italy 11 85 0.6× 232 1.7× 73 0.6× 47 0.5× 57 0.7× 16 445
Jean Costa Nunes Brazil 16 214 1.4× 230 1.7× 67 0.6× 212 2.3× 50 0.6× 36 724
Jean K. Ho United States 16 43 0.3× 162 1.2× 50 0.4× 37 0.4× 88 1.1× 28 528
F.W. Vreeling Netherlands 12 348 2.3× 110 0.8× 85 0.7× 139 1.5× 88 1.1× 22 638
Sara Pompanin Italy 8 96 0.6× 68 0.5× 31 0.3× 47 0.5× 46 0.6× 13 339
David W. Boorman United States 14 74 0.5× 113 0.8× 48 0.4× 46 0.5× 45 0.6× 29 752
Kazem Ghaemi Iran 11 95 0.6× 64 0.5× 60 0.5× 44 0.5× 25 0.3× 21 352
Dragoslav Sokić Serbia 14 186 1.2× 361 2.7× 84 0.7× 119 1.3× 30 0.4× 57 688
Gary W. Jay United States 10 51 0.3× 247 1.9× 74 0.6× 75 0.8× 91 1.2× 21 515
Claus Madsen Denmark 9 209 1.4× 52 0.4× 46 0.4× 47 0.5× 265 3.4× 13 560

Countries citing papers authored by Barent DuBois

Since Specialization
Citations

This map shows the geographic impact of Barent DuBois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barent DuBois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barent DuBois more than expected).

Fields of papers citing papers by Barent DuBois

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barent DuBois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barent DuBois. The network helps show where Barent DuBois may publish in the future.

Co-authorship network of co-authors of Barent DuBois

This figure shows the co-authorship network connecting the top 25 collaborators of Barent DuBois. A scholar is included among the top collaborators of Barent DuBois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barent DuBois. Barent DuBois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Douros, Jonathan D., Megan E. Capozzi, Jacek Mokrosiński, et al.. (2025). 1685-P: Ectopic Hepatic GLP-1R Agonism Enhances the Weight Loss Efficacy of GLP-1 Analogues. Diabetes. 74(Supplement_1). 1 indexed citations
2.
Shankar, Kripa, Nathan P. Metzger, Deepali Gupta, et al.. (2024). A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in mice. Molecular Metabolism. 84. 101950–101950. 10 indexed citations
3.
Yang, Bin, Vasily M. Gelfanov, Kimberley El, et al.. (2022). Discovery of a potent GIPR peptide antagonist that is effective in rodent and human systems. Molecular Metabolism. 66. 101638–101638. 34 indexed citations
5.
DuBois, Barent, et al.. (2021). UPLC-MS/MS analysis of the Michaelis-Menten kinetics of CYP3A-mediated midazolam 1′- and 4-hydroxylation in rat brain microsomes. Journal of Chromatography B. 1180. 122892–122892. 4 indexed citations
6.
7.
Yang, Bin, Vasily M. Gelfanov, Diego Pérez–Tilve, et al.. (2021). Optimization of Truncated Glucagon Peptides to Achieve Selective, High Potency, Full Antagonists. Journal of Medicinal Chemistry. 64(8). 4697–4708. 14 indexed citations
8.
Singh, Harleen, et al.. (2019). Pharmacogenomics in the Clinic: Genetic Polymorphism Contributing to Venlafaxine-Associated Heart Failure. Pharmacogenomics. 20(17). 1175–1178. 1 indexed citations
9.
DuBois, Barent, et al.. (2018). In vitro and ex-vivo evaluation of topical formulations designed to minimize transdermal absorption of Vitamin K1. PLoS ONE. 13(10). e0204531–e0204531. 2 indexed citations
10.
DuBois, Barent & Reza Mehvar. (2018). UPLC-MS/MS analysis of dextromethorphan-O-demethylation kinetics in rat brain microsomes. Journal of Chromatography B. 1096. 66–72. 7 indexed citations
11.
12.
Singh, Harleen, Barent DuBois, & Thomas Barrett. (2016). Pharmacogenomics in the Clinic: A Case Report of CYP2D6 and CYP2C19 Polymorphisms Contributing to Venlafaxine Associated Heart Failure. Journal of Cardiac Failure. 22(8). S132–S132.
13.
DuBois, Barent, Samantha Louey, G Giraud, Ganesh Cherala, & Sonnet S. Jonker. (2015). Theophylline Pharmacokinetics in Foetal Sheep: Maternal Metabolic Capacity is the Principal Driver. Basic & Clinical Pharmacology & Toxicology. 117(4). 226–233. 1 indexed citations
14.
DuBois, Barent, et al.. (2015). Furosemide Pharmacokinetics in Adult Rats become Abnormal with an Adverse Intrauterine Environment and Modulated by a Post‐Weaning High‐Fat Diet. Basic & Clinical Pharmacology & Toxicology. 118(6). 432–439. 3 indexed citations
15.
DuBois, Barent, Jessica Atrio, Frank Z. Stanczyk, & Ganesh Cherala. (2014). Increased exposure of norethindrone in HIV+ women treated with ritonavir-boosted atazanavir therapy. Contraception. 91(1). 71–75. 14 indexed citations
16.
DuBois, Barent, et al.. (2014). Perinatal growth restriction decreases diuretic action of furosemide in adult rats. European Journal of Pharmacology. 728. 39–47. 10 indexed citations
18.
Edelman, Alison, Ganesh Cherala, Myrna Y. Munar, et al.. (2012). Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered pharmacokinetic profile in obese oral contraceptives users. Contraception. 87(2). 220–226. 32 indexed citations
19.
DuBois, Barent, et al.. (2012). Maternal obesity alters feto-placental cytochrome P4501A1 activity. Placenta. 33(12). 1045–1051. 15 indexed citations
20.
Pillon, B., Bernard Deweer, Yves Agid, & Barent DuBois. (1993). Explicit Memory in Alzheimer's, Huntington's, and Parkinson's Diseases. Archives of Neurology. 50(4). 374–379. 248 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026